Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Dr. Tebo, et al, reply.

Tebo AE, Schmidt RL, Frech TM.

J Rheumatol. 2019 Aug 1. pii: jrheum.190594. doi: 10.3899/jrheum.190594. [Epub ahead of print]

PMID:
31371652
2.

Laboratory Evaluation of Antiphospholipid Syndrome.

Heikal N, Martins TB, White SK, Willis R, Ware Branch D, Schmidt RL, Tebo AE.

Am J Clin Pathol. 2019 Oct 7;152(5):638-646. doi: 10.1093/ajcp/aqz085.

PMID:
31305881
3.

Presence of Antitopoisomerase I Antibody Alone May Not Be Sufficient for the Diagnosis of Systemic Sclerosis.

Tebo AE, Schmidt RL, Frech TM.

J Rheumatol. 2019 Apr;46(4):440-442. doi: 10.3899/jrheum.180503. Epub 2019 Mar 1. No abstract available.

PMID:
30824655
4.

Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study.

Gibbins KJ, Tebo AE, Nielsen SK, Branch DW.

Lupus. 2018 Oct;27(12):1903-1910. doi: 10.1177/0961203318787035. Epub 2018 Jul 20.

5.

Assessment of diagnostic methods for the detection of anticardiolipin and anti-βeta2 glycoprotein I antibodies in patients under routine evaluation for antiphospholipid syndrome.

Martins TB, Heikal N, Miller J, Willis R, Schmidt RL, Tebo AE.

Clin Chim Acta. 2018 Oct;485:7-13. doi: 10.1016/j.cca.2018.06.008. Epub 2018 Jun 5.

PMID:
29883633
6.

Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort.

Peterson LK, Jaskowski TD, La'ulu SL, Tebo AE.

Immunol Res. 2018 Jun;66(3):431-436. doi: 10.1007/s12026-018-9006-7.

PMID:
29845587
7.

Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies.

Tebo AE.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00270-17. doi: 10.1128/CVI.00270-17. Print 2017 Dec. Review.

8.

Detection of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme a reductase by ELISA in a reference laboratory setting.

Jaskowski TD, La'ulu SL, Mahler M, Tebo AE.

Clin Chim Acta. 2017 Sep;472:30-34. doi: 10.1016/j.cca.2017.07.011. Epub 2017 Jul 11.

PMID:
28709800
9.

A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice.

Chiaro TR, Soto R, Zac Stephens W, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W, Brown J, Stillman DJ, O'Connell RM, Tebo AE, Round JL.

Sci Transl Med. 2017 Mar 8;9(380). pii: eaaf9044. doi: 10.1126/scitranslmed.aaf9044. Erratum in: Sci Transl Med. 2017 May 3;9(388):.

10.

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.

Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K, Favas C, Delgado Alves J, Žigon P, Ambrožič A, Tomšič M, Ruiz-Arruza I, Ruiz-Irastorza G, Bertolaccini ML, Norman GL, Shums Z, Arai J, Murashima A, Tebo AE, Gerosa M, Meroni PL, Rodriguez-Pintó I, Cervera R, Swadzba J, Musial J, Atsumi T.

Lupus. 2017 Mar;26(3):266-276. doi: 10.1177/0961203316660203. Epub 2016 Aug 20.

PMID:
27510605
11.

Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.

Nandiwada SL, Peterson LK, Mayes MD, Jaskowski TD, Malmberg E, Assassi S, Satoh M, Tebo AE.

J Rheumatol. 2016 Oct;43(10):1816-1824. Epub 2016 Aug 1.

PMID:
27481902
12.

Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.

Tebo AE, Willis R, Jaskowski TD, Guerra M, Pierangeli SS, Salmon J, Petri M, Branch DW.

Clin Chim Acta. 2016 Sep 1;460:107-13. doi: 10.1016/j.cca.2016.06.025. Epub 2016 Jun 23.

PMID:
27346478
13.

Autoantibody diversity in paraneoplastic syndromes and related disorders: The need for a more guided screening approach.

Tebo AE, Haven TR, Jackson BR.

Clin Chim Acta. 2016 Aug 1;459:162-169. doi: 10.1016/j.cca.2016.06.006. Epub 2016 Jun 7.

PMID:
27287529
14.

Performance Characteristics of Commercial Immunoassays for the Detection of IgG and IgM Antibodies to β2 Glycoprotein I and an Initial Assessment of Newly Developed Reference Materials for Assay Calibration.

Willis R, Pierangeli SS, Jaskowski TD, Malmberg E, Guerra M, Salmon JE, Petri M, Branch DW, Tebo AE.

Am J Clin Pathol. 2016 Jun;145(6):796-805. doi: 10.1093/ajcp/aqw065. Epub 2016 Jun 6.

PMID:
27267373
15.

Comparative analysis of neutrophil gelatinase-associated lipocalin and other laboratory markers for lupus nephritis: a cross-sectional investigation.

La'ulu SL, Suh-Lailam BB, Davis KW, Straseski JA, Tebo AE.

Ann Clin Biochem. 2017 Mar;54(2):240-245. doi: 10.1177/0004563216651888. Epub 2016 Sep 28.

PMID:
27166308
16.

Antibodies to Phosphatidylserine/Prothrombin Complex in Antiphospholipid Syndrome: Analytical and Clinical Perspectives.

Peterson LK, Willis R, Harris EN, Branch WD, Tebo AE.

Adv Clin Chem. 2016;73:1-28. doi: 10.1016/bs.acc.2015.10.003. Epub 2016 Jan 13. Review.

PMID:
26975968
17.

Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.

Peterson LK, Jaskowski TD, Mayes MD, Tebo AE.

Immunol Res. 2016 Apr;64(2):483-8. doi: 10.1007/s12026-015-8710-9.

PMID:
26467972
18.

Commentary.

Tebo AE.

Clin Chem. 2015 Sep;61(9):1136-7. doi: 10.1373/clinchem.2014.236877. No abstract available.

19.

Immunoassays for the detection of IgA antibodies to tissue transglutaminase: significance of multiples of the upper limit of normal and inter-assay correlations.

Suh-Lailam BB, Davis KW, Tebo AE.

Clin Chem Lab Med. 2016 Feb;54(2):257-64. doi: 10.1515/cclm-2015-0348.

PMID:
26172170
20.

Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.

Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.

Clin Exp Immunol. 2015 May;180(2):218-26. doi: 10.1111/cei.12573.

21.

Clinical laboratory immunology: an indispensable player in laboratory medicine.

Tebo AE, Detrick B, Hamilton RG, Khanolkar A, O'Gorman MR, Schmitz JL, Abraham RS.

Am J Clin Pathol. 2014 Oct;142(4):437-44. doi: 10.1309/AJCPX25MFWNEYRIG. Review.

PMID:
25239409
22.
23.

Autoimmune NMDA receptor encephalitis.

Lazar-Molnar E, Tebo AE.

Clin Chim Acta. 2015 Jan 1;438:90-7. doi: 10.1016/j.cca.2014.08.010. Epub 2014 Aug 20. Review.

PMID:
25149104
24.

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.

Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, de Groot P, Lakos G, Lambert M, Meroni P, Ortel TL, Petri M, Rahman A, Roubey R, Sciascia S, Snyder M, Tebo AE, Tincani A, Willis R.

Autoimmun Rev. 2014 Sep;13(9):917-30. doi: 10.1016/j.autrev.2014.05.001. Epub 2014 May 10. Review.

PMID:
24824074
25.

Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay.

Suh-Lailam BB, Haven TR, Copple SS, Knapp D, Jaskowski TD, Tebo AE.

Clin Chim Acta. 2013 Jun 5;421:1-6. doi: 10.1016/j.cca.2013.02.010. Epub 2013 Feb 27.

PMID:
23454475
26.

Testing for antireticulin antibodies in patients with celiac disease is obsolete: a review of recommendations for serologic screening and the literature.

Nandiwada SL, Tebo AE.

Clin Vaccine Immunol. 2013 Apr;20(4):447-51. doi: 10.1128/CVI.00568-12. Epub 2013 Jan 30. Review.

27.

The entire predictive value of the prometheus IBD sgi diagnostic product may be due to the three least expensive and most available components.

Shirts B, von Roon AC, Tebo AE.

Am J Gastroenterol. 2012 Nov;107(11):1760-1. doi: 10.1038/ajg.2012.238. No abstract available.

PMID:
23160303
28.

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.

Tebo AE, Jaskowski T, Davis KW, Whiting A, Clifford B, Zeft A, McNally B, Hill HR, Bohnsack J, Prahalad S.

Pediatr Rheumatol Online J. 2012 Aug 29;10(1):29. doi: 10.1186/1546-0096-10-29.

29.

APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.

Int J Clin Exp Pathol. 2012;5(3):210-5. Epub 2012 Mar 25.

30.

Evaluation of a high avidity anti-dsDNA IgG enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.

Suh-Lailam BB, Chiaro TR, Davis K W, Wilson AR, Tebo AE.

Int J Clin Exp Pathol. 2011;4(8):748-54. Epub 2011 Oct 30.

31.

Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis.

Copple SS, Sawitzke AD, Wilson AM, Tebo AE, Hill HR.

Am J Clin Pathol. 2011 May;135(5):678-84. doi: 10.1309/AJCP6R8EELGODAYW.

PMID:
21502422
32.

Diagnostic assays for anti-PM/Scl IgG antibodies: heterogeneity in antibody response or lack of standardization?

Jaskowski TD, Wilson A, Hill HR, Tebo AE.

Clin Chim Acta. 2011 May 12;412(11-12):1100-5. doi: 10.1016/j.cca.2011.02.031. Epub 2011 Mar 1.

PMID:
21371448
33.

Significant differences in the analytic concordance between anti-dsDNA IgG antibody assays for the diagnosis of systemic lupus erythematosus--implications for inter-laboratory testing.

Chiaro TR, Davis KW, Wilson A, Suh-Lailam B, Tebo AE.

Clin Chim Acta. 2011 May 12;412(11-12):1076-80. doi: 10.1016/j.cca.2011.02.025. Epub 2011 Feb 23.

PMID:
21352819
34.

'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.

Bertolaccini ML, Amengual O, Atsumi T, Binder WL, de Laat B, Forastiero R, Kutteh WH, Lambert M, Matsubayashi H, Murthy V, Petri M, Rand JH, Sanmarco M, Tebo AE, Pierangeli SS.

Lupus. 2011 Feb;20(2):191-205. doi: 10.1177/0961203310397082.

PMID:
21303836
35.

An algorithm for acetylcholine receptor antibody testing in patients with suspected myasthenia gravis.

Haven TR, Astill ME, Pasi BM, Carper JB, Wu LL, Tebo AE, Hill HR.

Clin Chem. 2010 Jun;56(6):1028-9. doi: 10.1373/clinchem.2009.140392. Epub 2010 Apr 1. No abstract available.

36.

Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.

Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, Bender JM, Pasi BM, Chinen J, Hanson IC, de Boer M, Roos D, Wittwer CT.

J Mol Diagn. 2010 May;12(3):368-76. doi: 10.2353/jmoldx.2010.090147. Epub 2010 Mar 12.

37.

Performance characteristics of three random access cyclic citrullinated peptide antibody assays.

Wyness SP, La'ulu SL, Hunsaker JJ, Tebo AE, Roberts WL.

Clin Chim Acta. 2010 Mar;411(5-6):428-32. doi: 10.1016/j.cca.2009.12.017. Epub 2010 Jan 7.

PMID:
20060386
38.

Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?

Jaskowski TD, Wilson AR, Hill HR, Branch WD, Tebo AE.

Clin Chim Acta. 2009 Dec;410(1-2):19-24. doi: 10.1016/j.cca.2009.09.006. Epub 2009 Sep 12.

PMID:
19751711
39.

Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss.

Tebo AE, Jaskowski TD, Hill HR, Branch DW.

Clin Exp Immunol. 2008 Dec;154(3):332-8. doi: 10.1111/j.1365-2249.2008.03774.x. Epub 2008 Sep 23.

40.

Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis.

Prahalad S, Martins TB, Tebo AE, Whiting A, Clifford B, Zeft AS, McNally B, Bohnsack JF, Hill HR.

Pediatr Rheumatol Online J. 2008 May 28;6:8. doi: 10.1186/1546-0096-6-8.

41.

Diagnostic performance of phospholipid-specific assays for the evaluation of antiphospholipid syndrome.

Tebo AE, Jaskowski TD, Phansalkar AR, Litwin CM, Branch DW, Hill HR.

Am J Clin Pathol. 2008 Jun;129(6):870-5. doi: 10.1309/6MPULFBL24FM9B50.

PMID:
18480002
42.

Comparison of immune assays for the detection of anti-HSP70 antibodies in patients with idiopathic sensorineural hearing loss.

Tebo AE, Jaskowski TD, Keith LL, Litwin CM, Hill HR.

Clin Chim Acta. 2007 Jun;381(2):140-4. Epub 2007 Mar 12.

PMID:
17434470
43.
44.

Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses.

Tebo AE, Fuller MJ, Gaddis DE, Kojima K, Rehani K, Zajac AJ.

J Virol. 2005 Oct;79(20):12703-13.

45.

Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help.

Fuller MJ, Hildeman DA, Sabbaj S, Gaddis DE, Tebo AE, Shang L, Goepfert PA, Zajac AJ.

J Immunol. 2005 May 15;174(10):5926-30.

46.

Temporal variations in immune responses to conserved regions of Plasmodium falciparum merozoite surface proteins related to the severity of a prior malaria episode in Gabonese children.

Köhler C, Tebo AE, Dubois B, Deloron P, Kremsner PG, Luty AJ; 1-95/C Study Team.

Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):455-61.

PMID:
15259482
47.

Transmission of Plasmodium falciparum in urban Yaoundé, Cameroon, is seasonal and age-dependent.

van der Kolk M, Tebo AE, Nimpaye H, Ndombol DN, Sauerwein RW, Eling WM.

Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):375-9.

PMID:
15259460
48.

Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections.

Fuller MJ, Khanolkar A, Tebo AE, Zajac AJ.

J Immunol. 2004 Apr 1;172(7):4204-14.

49.

Supplemental Content

Support Center